Effects of pioglitazone on cardiovascular events and all-cause mortality in patients with type 2 diabetes: A meta-analysis of randomized controlled trials

Rivista
Nutrition, Metabolism and Cardiovascular Diseases
Autori
Mannucci E, Giaccari A, Gallo M, Targher G, Pintaudi B, Candido R, Monami M; on behalf of the SID-AMD joint panel for Italian Guidelines on Treatment of Type 2 Diabetes
Citazione bibliografica
2022 Mar;32(3):529-536
DOI
10.1016/j.numecd.2021.12.006